• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Daniel Ran

    3/25/26 11:29:47 AM ET
    $NNOX
    Medical Electronics
    Health Care
    Get the next $NNOX alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Daniel Ran

    (Last)(First)(Middle)
    104-20 QUEENS BLVD.
    15J

    (Street)
    FOREST HILLS NEW YORK 11375

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Nano-X Imaging Ltd. [ NNOX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    CFO
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    03/18/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Ordinary shares03/18/2026D39,474A$046,424D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    Remarks:
    The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on March 18, 2026 and of which 50% will vest on the 12-month anniversary of the grant date and the remaining 50% will vest upon the 24-month anniversary of the grant date.
    Ran Daniel03/25/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $NNOX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNOX

    DatePrice TargetRatingAnalyst
    7/7/2026$3.00Buy → Neutral
    Alliance Global Partners
    1/6/2025$23.00Buy
    D. Boral Capital
    9/8/2023$14.50Buy
    Alliance Global Partners
    1/5/2023$21.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $NNOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    6/15/26 4:05:24 PM ET
    $NNOX
    Medical Electronics
    Health Care

    New insider Suesskind Dan S claimed ownership of 25,336 units of Ordinary shares (SEC Form 3)

    3 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    4/30/26 2:31:47 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Yahav Attias Gali

    3 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    4/9/26 7:31:56 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026

    New SCCT abstracts from Brigham and Women’s Hospital highlight the performance and clinical utility of Nanox.AI’s FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its potential role in supporting guideline-directed preventive care. From incidental finding to clinical action: the AI INFORM randomized trial highlights how AI-detected coronary calcium may help clinicians identify opportunities for preventive lipid-lowering therapy. Nanox.AI Sponsors SCCT Scientific Session, "From Missed Finding to Missed Opportunity: Aortic Valve Calcification on Chest CT," Featuring Ofir Koren, MD, Cedars-Sinai Medical Center, on Sunday, July 12, at 7:30 am PETACH TIKVA, Is

    7/7/26 8:10:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

    PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2026, before market open on Thursday, June 25, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2026 Call Registration The live webcast of the conference call may be accessed

    6/11/26 4:01:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    Exclusive distribution agreement marks Nanox's entry into the Peruvian market

    Initial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (("Nanox", NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Top Med SAC ("Top Med") to deploy the Nanox.ARC system and related services in Peru. Under the agreement, Nanox appointed Top Med as its exclusive distributor of the Nanox.ARC system and Nanox platform in Peru, subject to commercial milestones and regulatory requirements. The agreement is structured as a capex model and includes an expected initial deployment of six Nanox.ARC systems, subject to receipt of t

    6/2/26 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nano-X Imaging downgraded by Alliance Global Partners with a new price target

    Alliance Global Partners downgraded Nano-X Imaging from Buy to Neutral and set a new price target of $3.00

    7/7/26 8:44:27 AM ET
    $NNOX
    Medical Electronics
    Health Care

    D. Boral Capital initiated coverage on Nano-X Imaging with a new price target

    D. Boral Capital initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $23.00

    1/6/25 9:02:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Alliance Global Partners initiated coverage on Nano-X Imaging with a new price target

    Alliance Global Partners initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $14.50

    9/8/23 9:14:06 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    SEC Filings

    View All

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    6/25/26 8:05:01 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by NANO-X IMAGING LTD

    SCHEDULE 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    5/15/26 6:11:44 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 20-F filed by NANO-X IMAGING LTD

    20-F - Nano-X Imaging Ltd. (0001795251) (Filer)

    4/30/26 4:03:41 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Leadership Updates

    Live Leadership Updates

    View All

    Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

    NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. "Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "As we

    5/3/21 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Financials

    Live finance-specific insights

    View All

    Nanox to Report First Quarter 2026 Financial Results on June 25, 2026

    PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2026, before market open on Thursday, June 25, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2026 Call Registration The live webcast of the conference call may be accessed

    6/11/26 4:01:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

    Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI Management to host conference call and webcast Monday, April 20, 2026 at 8:30 AM ET Appointed new CFO effective August 1, 2026 PETAH TIKVA, Israel, April 20, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2025, and provided a business update. Recent Highlights: Generated $3.7 million in revenue in the fourth quarter of 2025, compared to $3.0 million in the fourth quarter o

    4/20/26 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026

    PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended December 31, 2025, before market open on Monday, April 20, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 2025 Call The live webcast of the conference call may be accessed by using t

    4/6/26 4:05:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Daniel Ran bought $3,650 worth of Ordinary shares (1,000 units at $3.65), increasing direct ownership by 17% to 6,950 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 5:41:26 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    3/7/24 12:29:51 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by NANO-X IMAGING LTD

    SC 13G - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/6/24 9:36:34 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/14/23 4:15:16 PM ET
    $NNOX
    Medical Electronics
    Health Care